Croatia-based food-to-pharma group Podravka has reported a near-8% rise in sales for 2015, with its food division, including the newly-acquired Slovenian pasta-to-confectionery group Zito, offsetting lower sales in pharmaceuticals.
The company booked a 7.8% increase in group turnover to HRK3.78bn for last year. Podravka said its food division, which includes Vegeta spices, Lino baby food and Talianetta pasta, saw its sales rise 11.6% to HRK2.97bn.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Last year’s acquisition of Zito – the largest in Podravka’s history – added to the company’s top line from October.
Including Zito, Podravka said sales of its own brands were up over 13% in 2015, compensating for lower sales from its commercial foods division.
Revenue from pharmaceuticals dropped 4.1%. Podravka has started building two new pharma plants to bolster that side of its business.
Podravka’s group net profit was HRK398m in 2015, up sharply from HRK92.5m a year earlier. The company pointed to the positive impact of the Zito acquisition, as well as realised tax income connected to incentives for the construction of the new pharma factories.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
